Related references
Note: Only part of the references are listed.Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment
F. Manapov et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2012)
Interval Between Breast-Conserving Surgery and Start of Radiation Therapy in Early-Stage Breast Cancer is Not Predictive of Local Recurrence: A Single-Institution Experience
Viviana Barbieri et al.
CLINICAL BREAST CANCER (2011)
PROLONGATION OF TOTAL TREATMENT TIME BECAUSE OF INFREQUENTLY MISSED DAYS OF TREATMENT IS NOT ASSOCIATED WITH INFERIOR BIOCHEMICAL OUTCOME AFTER DOSE-ESCALATED RADIATION THERAPY FOR PROSTATE CANCER
Stanley L. Liauw et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) Gy
Raymond Miralbell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995
Howard D. Thames et al.
RADIOTHERAPY AND ONCOLOGY (2010)
DOES TREATMENT DURATION AFFECT OUTCOME AFTER RADIOTHERAPY FOR PROSTATE CANCER?
David J. D'Ambrosio et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Hypofractionation for prostate cancer: A critical review
Edward F. Miles et al.
SEMINARS IN RADIATION ONCOLOGY (2008)
Use of individual fraction size data from 3756 patients to directly determine the α/β ratio of prostate cancer
Scott G. Williams et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Concordance probability and discriminatory power in proportional hazards regression
M Gönen et al.
BIOMETRIKA (2005)
Randomized trial comparing two fractionation schedules for patients with localized prostate cancer
H Lukka et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer
J Hiratsuka et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: Early results of a phase III randomized trial
EEK Yeoh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Practical methods for compensating for missed treatment days in radiotherapy, with particular reference to head and neck schedules
RG Dale et al.
CLINICAL ONCOLOGY (2002)
Share Paper
